Another under-$10 stock that looks ready to trigger a near-term breakout trade is Depomed (DEPO - Get Report), which is a specialty pharmaceutical company initially focused on neurology, pain and other diseases of the central nervous system. This stock has been soaring higher during the last six months, with shares up 34.9%.
This biotech player has a major catalyst on the horizon. On March 4, the FDA will hold an advisory committee meeting for their drug Serada to evaluate whether it is a safe and efficacious treatment for menopausal hot flashes.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts